Coeliac disease is an immune‐mediated enteropathy, triggered in genetically susceptible people by dietary gluten.1 Diagnosis has historically been based on positive serological test results (such as elevated anti‐tissue transglutaminase [tTG] or endomysial antibody levels) together with characteristic histological features identified by small bowel biopsy in people with typical symptoms. However, serological diagnosis (without small bowel biopsy) may be considered in children.2 In Australia, an estimated 1.2% of men and 1.9% of women have coeliac disease,3 while an electoral roll‐based study determined a rate of 1.2% in Christchurch, New Zealand.4 Both figures are consistent with the estimated pooled global prevalence of 1.4%.5
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Andrew Day's research activities are supported by Cure Kids.
Andrew Day has received speaking fees from AbbVie.